Key result
Regulatory noncoding RNAs critically govern aging-associated cardiovascular homeostasis and disease.
Answers are grounded in this paper and cite their sources.
Eukaryotic gene expression is tightly regulated transcriptionally and post-transcriptionally by a host of noncoding (nc)RNAs. The best-studied class of short ncRNAs, microRNAs, mainly repress gene expression post-transcriptionally. Long noncoding (lnc)RNAs, which comprise RNAs differing widely in length and function, can regulate gene transcription as well as post-transcriptional mRNA fate. Collectively, ncRNAs affect a broad range of age-related physiologic deteriorations and pathologies, including reduced cardiovascular vigor and age-associated cardiovascular disease. This review presents an update of our understanding of regulatory ncRNAs contributing to cardiovascular health and disease as a function of advancing age. We will discuss (1) regulatory ncRNAs that control aging-associated cardiovascular homeostasis and disease, (2) the concepts, approaches, and methodologies needed to study regulatory ncRNAs in cardiovascular aging and (3) the challenges and opportunities that age-associated regulatory ncRNAs present in cardiovascular physiology and pathology. This article is part of a Special Issue entitled "CV Aging".
No takes yet. Share an insight, caveat, or question.
Greco et al. (2015) conducted a review in Age-related cardiovascular diseases. Noncoding RNA was evaluated. Regulatory noncoding RNAs, including microRNAs and long noncoding RNAs, play critical roles in controlling aging-associated cardiovascular homeostasis and disease.
Synapse has enriched 10 related papers. Consider them for comparative context: